Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19. - Jones RS; Smith PS; Berg PH; de la Peña A; Cook PP; Shawa I; Kioussopoulos KM; Hu Y; Schott RJ (Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 2022)